Meyahealth
HomeGeneticsConditionFamilial porencephaly
Back to Condition
Familial porencephaly
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Familial porencephaly

Familial porencephaly is a rare, autosomal dominant disorder caused by mutations in COL4A1. It leads to fragile brain blood vessels, cysts, and a spectrum of neurological symptoms.

Overview

Familial porencephaly is part of a group of conditions called the COL4A1-related disorders. The conditions in this group have a range of signs and symptoms that involve fragile blood vessels. In familial porencephaly, fluid-filled cysts develop in the brain (porencephaly) during fetal development or soon after birth. These cysts typically occur in only one side of the brain and vary in size. The cysts are thought to be the result of bleeding within the brain (). People with this condition also have leukoencephalopathy, which is a change in a type of brain tissue called white matter that can be seen with magnetic resonance imaging (MRI).

During infancy, people with familial porencephaly typically have paralysis affecting one side of the body (infantile hemiplegia). Affected individuals may also have recurrent seizures (epilepsy), migraine headaches, speech problems, intellectual disability, and uncontrolled muscle tensing (dystonia). Some people are severely affected, and others may have no symptoms related to the brain cysts.

Frequency

Familial porencephaly is a rare condition, although the exact prevalence is unknown. At least eight affected families have been described in the scientific literature.

Causes & Risk Factors

Mutations in the COL4A1 gene cause familial porencephaly. The COL4A1 gene provides instructions for making one component of a protein called type IV collagen. Type IV collagen molecules attach to each other to form complex protein networks. These protein networks are the main components of basement membranes, which are thin sheet-like structures that separate and support cells in many tissues. Type IV collagen networks play an important role in the basement membranes in virtually all tissues throughout the body, particularly the basement membranes surrounding the body's blood vessels (vasculature).

The COL4A1 gene mutations that cause familial porencephaly result in the production of a protein that disrupts the structure of type IV collagen. As a result, type IV collagen molecules cannot attach to each other to form the protein networks in basement membranes. Basement membranes without normal type IV collagen are unstable, leading to weakening of the tissues that they surround. In people with familial porencephaly, the vasculature in the brain weakens, which can lead to blood vessel breakage and . Bleeding within the brain is followed by the formation of fluid-filled cysts characteristic of this condition. It is thought that the pressure and stress on the head during birth contributes to vessel breakage in people with this condition; however in some individuals, bleeding in the brain can occur before birth.

Learn more about the gene associated with Familial porencephaly

  • COL4A1

Inheritance

This condition is inherited in an , which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Other Names for This Condition

  • Autosomal dominant porencephaly type 1
  • Infantile hemiplegia with porencephaly
  • Porencephaly type 1

Additional Information & Resources

Genetic Testing Information

  • Genetic Testing Registry: Familial porencephaly

Genetic and Rare Diseases Information Center

  • Familial porencephaly

Patient Support and Advocacy Resources

  • National Organization for Rare Disorders (NORD)

Clinical Trials

  • ClinicalTrials.gov

Catalog of Genes and Diseases from OMIM

  • BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1

Scientific Articles on PubMed

  • PubMed

References

  • Breedveld G, de Coo IF, Lequin MH, Arts WF, Heutink P, Gould DB, John SW, Oostra B, Mancini GM. Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly. J Med Genet. 2006 Jun;43(6):490-5. doi: 10.1136/jmg.2005.035584. Epub 2005 Aug 17. Citation on PubMed or Free article on PubMed Central
  • Meuwissen ME, de Vries LS, Verbeek HA, Lequin MH, Govaert PP, Schot R, Cowan FM, Hennekam R, Rizzu P, Verheijen FW, Wessels MW, Mancini GM. Sporadic COL4A1 mutations with extensive prenatal porencephaly resembling hydranencephaly. Neurology. 2011 Mar 1;76(9):844-6. doi: 10.1212/WNL.0b013e31820e7751. No abstract available. Citation on PubMed
  • Vahedi K, Alamowitch S. Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease. Curr Opin Neurol. 2011 Feb;24(1):63-8. doi: 10.1097/WCO.0b013e32834232c6. Citation on PubMed

MEDICAL ENCYCLOPEDIA

  • Genetics

Understanding Genetics

  • What is the prognosis of a genetic condition?
  • How can gene variants affect health and development?
  • What does it mean if a disorder seems to run in my family?
  • What are the different ways a genetic condition can be inherited?
  • How are genetic conditions treated or managed?

MedlinePlus links to health information from the National Institutes of Health and other federal government agencies. MedlinePlus also links to health information from non-government Web sites. See our disclaimer about external links and our quality guidelines.

Frequently Asked Questions

n MRI of the brain is the gold standard for identifying cysts, white‑matter changes, and any associated hemorrhages. A CT scan may be used if MRI is unavailable or contraindicated. Once diagnosed, repeat imaging is typically scheduled every 1–2 years or sooner if the patient experiences new neurological symptoms, to monitor cyst growth or new lesions. How are seizures managed in children with familial porencephaly, and are there specific antiepileptic drugs that work best?::Seizure control often requires a combination of antiepileptic drugs (AEDs). Levetiracetam and valproic acid are commonly used first‑line agents because of their broad spectrum and tolerability. If seizures are refractory, adding lamotrigine or topiramate may be considered. A neurologist will tailor the regimen based on seizure type, frequency, and side‑effect profile, and may adjust doses as the child grows. What developmental or educational support is recommended for children with mild to moderate neurological deficits from porencephaly?::Early intervention programs that include physical therapy, occupational therapy, and speech therapy can improve motor skills, fine‑motor coordination, and communication. In school settings, individualized education plans (IEPs) that provide accommodations such as extended time, assistive technology, and specialized instruction can help children reach their academic potential. Regular assessments by a developmental pediatrician ensure timely adjustments to therapy and educational strategies. Can a family with a COL4A1 mutation reduce the risk of severe brain cysts in future pregnancies?::While the mutation itself cannot be prevented, prenatal counseling can discuss the variable expressivity of the condition. Prenatal imaging (ultrasound and fetal MRI) can detect cysts early, and if severe anomalies are identified, parents may consider options such as early delivery or, in some jurisdictions, termination. Additionally, some studies suggest that maternal hypertension or preeclampsia may worsen vascular fragility, so managing maternal health during pregnancy is important. Genetic counseling can provide individualized risk estimates and discuss reproductive options like PGD.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ